Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease
Launched by DUKE UNIVERSITY · Nov 30, 2021
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to measure peripheral vision, which is the ability to see things off to the side without turning your head. Instead of using a large machine that you sit at, this study uses a virtual reality system called VisuALL that you wear like goggles. The goal is to compare how well this new method works against the traditional visual field test. The study is looking for both healthy children and young adults, as well as those with eye conditions, who need this type of testing.
To participate, children must be 17 years old or younger, or young adults aged 18-21 who were diagnosed with their eye condition before turning 18. They should also be able to wear the goggles for at least 10 minutes and have a parent or guardian who can give consent. The test is simple and doesn’t involve touching the eyes or using eye drops. It will take about 30 minutes and can be done during a regular eye appointment at no extra cost. Participants will also receive a parking pass for their visit and may get to use a home version of the VisuALL system for additional testing later on. If your child is selected, more details will be shared.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients must be at least four (4) years old
- • Cognitively normal (no developmental delay or syndrome)
- • Be able to tolerate wearing the virtual reality goggles for at least 10 minutes
- • Be able to provide informed consent of a parent/guardian (and assent if 12 years or older)
- • Do not have any ocular diseases that could interfere with the visual field testing
- Exclusion Criteria:
- • Developmental delay
- • Inability to obtain consent
- • Inability to understand English
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Sharon F Freedman, MD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials